FDA commissioner search: New York cardiologist Weber is possible candidate.
Executive Summary
FDA COMMISSIONER CANDIDATE MICHAEL WEBER IS CARDIOLOGIST WITH ADVISORY COMMITTEE experience as a member of the Cardiovascular & Renal Drugs Advisory Committee since 1994. Michael Weber, MD, has been chair of the Brookdale University Department of Medicine since 1995. Weber, 53, is also professor of medicine and associate dean at the State University of New York Health Center. He has medical and undergraduate degrees from the University of Sydney and served his residency/fellowship at Nassau County Hospital and New York University Bellevue Hospital.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth